What's Behind Alexion Pharmaceuticals' Strong Q2 Results
Alexion Pharmaceuticals (NASDAQ: ALXN) stock has been on a big roll over the last few months. However, it hasn't been enough to outperform the S&P 500 index -- and Alexion's shares are still in negative territory year to date.
But Alexion provided good news to investors with its second-quarter results announced before the market opened on Thursday. Here are the highlights from the Q2 update.
Image source: Getty Images.
Source Fool.com
